Written by Precision subject matter experts Jeremy Schafer and Alexander Grosvenor, this new white paper features research and insights on differences in gene therapy development in the EU vs the US, as well as examines some of the key challenges facing gene therapy innovators.

Adapted from their recent presentation, the report looks at disparities between payer and manufacturer expectations for long-term outcomes and offers strategies for crafting compelling value stories.

Get this free, informative white paper today!